Commit To Buy Pulse Biosciences At $10, Earn 17.3% Annualized Using Options

A January 2026 $10 put on Pulse Biosciences Inc (PLSE) is highlighted for its 17.3% annualized return from a 70-cent premium, with potential share ownership at a $9.30 cost basis if the stock declines over 36% from current levels. Investors considering this strategy must weigh PLSE's high 67% trailing 12-month volatility. Concurrently, the broader market's S&P 500 put:call ratio reached 0.71 on Thursday, surpassing the long-term median of 0.65, indicating a notable increase in put volume.

Analysis

An analysis of Pulse Biosciences (PLSE) options highlights a specific strategy: selling the January 2026 put option with a $10 strike price. This trade offers a 17.3% annualized return based on the premium collected. However, this return is predicated on significant risk, as the position only becomes profitable if the stock remains above the strike price. Should the contract be exercised, the put seller would acquire shares at an effective cost basis of $9.30, a scenario that would occur only if PLSE's stock price declines by over 36.8% from its current level of $15.81. The feasibility of such a price move is underscored by the stock's high trailing twelve-month volatility of 67%. This level of volatility is the primary driver of the high premium but also indicates substantial underlying price risk. In the broader market context, the S&P 500 put-to-call ratio on the day of reporting was 0.71, which is elevated compared to the long-term median of 0.65, suggesting a higher-than-usual demand for put options and a potential increase in bearish sentiment or hedging activity across the market.

Key Decisions for Investors

• Investors with a high risk tolerance might consider selling the January 2026 $10 PLSE put to capture the 17.3% annualized yield, but only if they are comfortable with the company's fundamentals and willing to potentially acquire the stock at a $9.30 cost basis.
• The stock's exceptionally high 67% volatility materially increases the probability of the stock price falling below the $10 strike, so investors must weigh if the premium adequately compensates for the risk of being assigned a highly volatile asset after a significant downturn.
• Given the elevated S&P 500 put-to-call ratio indicating broader market caution, initiating a new, high-risk position in a volatile stock like PLSE warrants careful consideration of overall portfolio risk exposure.